skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
Material Type:
Article
Add to My Research

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma

Biologics, 2016-01, Vol.10, p.139-147 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Chávez-López et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S87402 ;PMID: 27703327

Full text available

2
Bevacizumab in the treatment of ovarian cancer
Material Type:
Article
Add to My Research

Bevacizumab in the treatment of ovarian cancer

Biologics, 2011-01, Vol.5 (default), p.1-5 [Peer Reviewed Journal]

2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Eskander and Randall, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S13071 ;PMID: 21383911

Full text available

3
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
Material Type:
Article
Add to My Research

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis

Biologics, 2012-01, Vol.6 (default), p.31-35 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Hasan et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S27840 ;PMID: 22355257

Full text available

4
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
Material Type:
Article
Add to My Research

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

Biologics, 2012-01, Vol.6 (default), p.83-87 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Lurati et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S29079 ;PMID: 22532776

Full text available

5
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Material Type:
Article
Add to My Research

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

Biologics, 2008-01, Vol.2 (4), p.823-843 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3770 ;PMID: 19707461

Full text available

6
Emerging role of multikinase inhibitors for refractory thyroid cancer
Material Type:
Article
Add to My Research

Emerging role of multikinase inhibitors for refractory thyroid cancer

Biologics, 2012-01, Vol.6 (default), p.257-265 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Perez et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S24465 ;PMID: 22904617

Full text available

7
Severe congenital protein C deficiency : the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
Material Type:
Article
Add to My Research

Severe congenital protein C deficiency : the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

Biologics, 2008-06, Vol.2 (2), p.285-296 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s1954 ;PMID: 19707361

Full text available

8
Safety of etanercept in elderly subjects with rheumatoid arthritis
Material Type:
Article
Add to My Research

Safety of etanercept in elderly subjects with rheumatoid arthritis

Biologics, 2010-01, Vol.4 (default), p.1-4 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Lurati et al, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S5492 ;PMID: 20161980

Full text available

9
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer
Material Type:
Article
Add to My Research

The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer

Biologics, 2008-01, Vol.2 (4), p.725-732 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Matsuyama and Yoshimura, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s3151 ;PMID: 19707453

Full text available

10
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
Material Type:
Article
Add to My Research

IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts

Biologics, 2008-09, Vol.2 (3), p.583-591 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Tamby et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3188 ;PMID: 19707389

Full text available

11
Rituximab therapy in Greek patients with rheumatoid arthritis
Material Type:
Article
Add to My Research

Rituximab therapy in Greek patients with rheumatoid arthritis

Biologics, 2008-01, Vol.2 (4), p.911-916 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Tsiakalos et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3939 ;PMID: 19707469

Full text available

12
Infliximab in the treatment of ankylosing spondylitis
Material Type:
Article
Add to My Research

Infliximab in the treatment of ankylosing spondylitis

Biologics, 2007-01, Vol.1 (2), p.163-171 [Peer Reviewed Journal]

Copyright Taylor & Francis Ltd. 2007 ;2007 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;PMID: 19707326

Full text available

Searching Remote Databases, Please Wait